Opiant Pharmaceuticals (OPNT) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	54.74M
Marketable securities	39.86M
Accounts receivable, net of $704 and $346 in allowance for doubtful accounts at June 30 and March 31, 2011, respectively	41.07M
Unbilled accounts receivable	2.71M
Inventory	1.29M
Deferred income taxes, prepaid expenses and other current assets	13.57M
Total current assets	153.24M
Property and equipment, net	16.23M
Intangible assets, net	7M
Goodwill	22.42M
Deferred income taxes and other assets	5.93M
Total assets	204.81M
Accounts payable	1.53M
Accrued liabilities	16.99M
Other income taxes	1.16M
Deferred rent	225K
Deferred revenue	46.3M
Total current liabilities	66.21M
Accrued liabilities	44K
Deferred rent	3.66M
Deferred revenue	6.8M
Other income taxes	811K
Total liabilities	77.52M
Commitments and contingencies (Note 12)	0
Common stock-par value $0.001; 100,000,000 shares authorized; 29,996,781 and 29,883,409 shares issued at June 30 and March 31, 2011, respectively; 22,336,305 and 22,228,504 shares outstanding at June 30 and March 31, 2011, respectively	31K
Additional paid-in capital	136.39M
Retained earnings	14.48M
Accumulated other comprehensive loss	-1.25M
Treasury stock, at cost-7,660,476 and 7,654,905 shares at June 30 and March 31, 2011, respectively	-22.36M
Total stockholders' equity	127.3M
Total liabilities and stockholders' equity	204.81M

Entities mentioned with OPNT

View All Entities